4 - Syra Health Corp (0001922335) (Issuer)

SC 13G - Syra Health Corp (0001922335) (Subject)

Achieved Net Revenue of $2.3 million, ~42% Growth Over the Prior Year Quarter Gross Margins Increased Following Shift in Operational Strategy Net Loss Narrowed to $417,535 ($0.06 per share), a Significant Improvement from the $1.39 million ($0.21 per share) Net Loss in Q2 of 2024 Aiming to Attain Profitability in 2025 through Targeted Revenue Growth and Cost-Efficiency Measures Conference call will be held today, Tuesday, October 29th at 9:00 AM ET CARMEL, Ind., Oct. 29, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company") a healthcare technology company driving better health through impactful, innovative solutions, announced today its financial results for

In the news release, Syra Health To Discuss Third Quarter 2024 Financial Results, issued 22-Oct-2024 by Syra Health over PR Newswire, we are advised by the company that the webcast link listed in the second and fourth paragraphs was incorrect. The URL should read "https://syrahealth.com/ir/presentations/q3-2024-earnings-call" rather than "https://dev.syrahealth.com/ir/presentations/q3-2024-earnings-call" as originally issued inadvertently. The complete, corrected release follows: Syra Health To Discuss Third Quarter 2024 Financial Results Conference call will be held on Tuesday, October 29 at 9:00 AM ET CARMEL, Ind., Oct. 22, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra He

Conference call will be held on Tuesday, October 29 at 9:00 AM ET CARMEL, Ind., Oct. 22, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today that it will report financial results for the three months ended September 30, 2024, on Tuesday, October 29, 2024, before the market opens. The Company has scheduled a conference call that same day, October 29, at 9:00 a.m. ET, to review the results. Interested parties can access the conference call

Conference call will be held today, Thursday, August 8 at 9:00 am ET CARMEL, Ind., Aug. 8, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company") a healthcare technology company powering better health by providing meaningful solutions, announced today its financial results for the second quarter ended June 30, 2024. Q2 2024 Financial Highlights Revenue of $2.0 million in 2Q24 compared to $1.0 million in 2Q23.Gross margins in 2Q24 increased 468 basis points compared to 2Q23.High-margin business units, including Population Health, grew 347% and co

Conference call will be held on Thursday, August 8 at 9:00 AM ET CARMEL, Ind., Aug. 1, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today that it will report financial results for the three months ended June 30, 2024, on Thursday, August 8, 2024, before the market opens. The Company has scheduled a conference call that same day, August 8, 2024, at 9:00 a.m. ET, to review the results. Interested parties can access the conference call via

Conference call will be held today, Thursday, May 9 at 9:00 am ET CARMEL, Ind., May 9, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company") a healthcare technology company with a mission to improve healthcare by providing innovative services and technology solutions, announced today its financial results for the first quarter ended March 31, 2024. Q1 2024 Financial Highlights Revenue of $1.7 million in 1Q24 compared to $1.2 million in 1Q23.Business units excluding Healthcare Workforce grew 333% and comprised 19% of total revenues in 1Q24, vers

Conference call will be held on Thursday, May 9 at 9:00 AM ET CARMEL, Ind., May 1, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company") a healthcare technology company with a mission to improve healthcare by providing innovative services and technology solutions, announced today that it will report financial results for its first quarter 2024 ended March 31, 2024, on Thursday, May 9, 2024, before the market opens. The Company has scheduled a conference call that same day, May 9, 2024, at 9:00 a.m. ET, to review the results. Interested parties

Conference call will be held today, Monday, March 25 at 9:00am ET CARMEL, Ind., March 25, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company"), a healthcare consulting company with a mission to improve healthcare by providing innovative services and technology solutions, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2023. 2023 Financial Highlights 2023 revenue of $5.5 million compared to $5.6 million in 2022.Business units excluding Healthcare Workforce grew 250% and comprised 23% of total reve

Conference call will be held on Monday, March 25 at 9:00 a.m. ET CARMEL, Ind., March 19, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company") a healthcare consulting company with a mission to improve healthcare by providing innovative services and technology solutions, announced today that it will report financial results for its fourth quarter and fiscal year 2023 ended December 31, 2023, on Monday, March 25, 2024, before the market opens. The Company has scheduled a conference call for that same day, March 25, 2024, at 9:00 a.m. ET, to review the results.

Achieved Net Revenue of $2.3 million, ~42% Growth Over the Prior Year Quarter Gross Margins Increased Following Shift in Operational Strategy Net Loss Narrowed to $417,535 ($0.06 per share), a Significant Improvement from the $1.39 million ($0.21 per share) Net Loss in Q2 of 2024 Aiming to Attain Profitability in 2025 through Targeted Revenue Growth and Cost-Efficiency Measures Conference call will be held today, Tuesday, October 29th at 9:00 AM ET CARMEL, Ind., Oct. 29, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company") a healthcare technology company driving better health through impactful, innovative solutions, announced today its financial results for

In the news release, Syra Health To Discuss Third Quarter 2024 Financial Results, issued 22-Oct-2024 by Syra Health over PR Newswire, we are advised by the company that the webcast link listed in the second and fourth paragraphs was incorrect. The URL should read "https://syrahealth.com/ir/presentations/q3-2024-earnings-call" rather than "https://dev.syrahealth.com/ir/presentations/q3-2024-earnings-call" as originally issued inadvertently. The complete, corrected release follows: Syra Health To Discuss Third Quarter 2024 Financial Results Conference call will be held on Tuesday, October 29 at 9:00 AM ET CARMEL, Ind., Oct. 22, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra He

Conference call will be held on Tuesday, October 29 at 9:00 AM ET CARMEL, Ind., Oct. 22, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today that it will report financial results for the three months ended September 30, 2024, on Tuesday, October 29, 2024, before the market opens. The Company has scheduled a conference call that same day, October 29, at 9:00 a.m. ET, to review the results. Interested parties can access the conference call

CARMEL, Ind., Oct. 9, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today more details about the award of three new healthcare workforce contracts: one in Florida, one in Kansas, and one in Delaware. In Florida, Syra Health has been awarded a contract to supply psychologists and school counselors to the St. John's County School District in St. Augustine. This effort underscores Syra's commitment to fostering mental health and well-being i

CARMEL, Ind., Oct. 1, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, is celebrating its first anniversary as a publicly traded company and highlighting its many successes. This milestone not only marks the Company's growth but also reflects its unwavering commitment to transforming healthcare service. As the Company highlights significant achievements over the past year, it remains focused on its mission to become a leader in healthcare solutions, empowering communities and improving health outcomes across the nation.

CARMEL, Ind., Sept. 13, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, today announced the closing of its previously announced public offering of an aggregate of 3,203,125 shares of its Class A common stock, Series A warrants to purchase up to 3,203,125 shares of Class A common stock and Series B warrants to purchase up to 3,203,125 shares of Class A common stock (all the warrants, collectively, the "Series Warrants"), at a combined public offering price of $0.64 per share and accompanying Series Warrants. The Series Warrants have an exercise price of $0.64 per s

CARMEL, Ind., Sept. 11, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, today announced the pricing of a public offering of an aggregate of 3,203,125 shares of its Class A common stock, Series A warrants to purchase up to 3,203,125 shares of Class A common stock and Series B warrants to purchase up to 3,203,125 shares of Class A common stock (all the warrants, collectively, the "Series Warrants"), at a combined public offering price of $0.64 per share  and accompanying Series Warrants. The Series Warrants will have an exercise price of $0.64 per share and will be

Conference call will be held today, Thursday, August 8 at 9:00 am ET CARMEL, Ind., Aug. 8, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company") a healthcare technology company powering better health by providing meaningful solutions, announced today its financial results for the second quarter ended June 30, 2024. Q2 2024 Financial Highlights Revenue of $2.0 million in 2Q24 compared to $1.0 million in 2Q23.Gross margins in 2Q24 increased 468 basis points compared to 2Q23.High-margin business units, including Population Health, grew 347% and co

Conference call will be held on Thursday, August 8 at 9:00 AM ET CARMEL, Ind., Aug. 1, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA), ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today that it will report financial results for the three months ended June 30, 2024, on Thursday, August 8, 2024, before the market opens. The Company has scheduled a conference call that same day, August 8, 2024, at 9:00 a.m. ET, to review the results. Interested parties can access the conference call via

Wyoming marks the 23rd state where Syra Health has active contracts CARMEL, Ind., July 30, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ:SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today that it has been awarded a population health contract by the Wyoming Department of Health, Behavioral Health Division. This marks Syra Health's entry into its 23rd state, further expanding its presence and reinforcing its commitment to improving population health nationwide. The contract, awarded u

4 - Syra Health Corp (0001922335) (Issuer)

4 - Syra Health Corp (0001922335) (Issuer)

4 - Syra Health Corp (0001922335) (Issuer)

4 - Syra Health Corp (0001922335) (Issuer)

4 - Syra Health Corp (0001922335) (Issuer)

4 - Syra Health Corp (0001922335) (Issuer)

3/A - Syra Health Corp (0001922335) (Issuer)

8-K - Syra Health Corp (0001922335) (Filer)

10-Q - Syra Health Corp (0001922335) (Filer)

8-K - Syra Health Corp (0001922335) (Filer)

8-K - Syra Health Corp (0001922335) (Filer)

424B4 - Syra Health Corp (0001922335) (Filer)

EFFECT - Syra Health Corp (0001922335) (Filer)

8-K - Syra Health Corp (0001922335) (Filer)

S-1 - Syra Health Corp (0001922335) (Filer)

8-K - Syra Health Corp (0001922335) (Filer)

10-Q - Syra Health Corp (0001922335) (Filer)

Syra Health Corp. (NASDAQ:SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today that it has been awarded a $5.8 million contract to train professionals who deliver health care to Indiana residents at home or in a community-based setting under the purview of the Indiana Family and Social Services Administration (FSSA). Syra Health has been selected to begin negotiating the contract which runs for four years with two additional one-year renewal options.

Syra Health Corp. (NASDAQ:SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today that it is giving away its AI developed by the Company for redacting personally identifiable information in line with HIPAA regulations. Syra Health is giving the configurable solution to the healthcare and technology community for its use in redacting personally identifiable information or for expanding on its use in new ways.

This is Syra Health's second active contract in the state of Missouri.

Gainers GT Biopharma (NASDAQ:GTBP) stock rose 153.2% to $7.9 during Monday's pre-market session. The company's market cap stands at $10.9 million. As per the press release, Q1 earnings came out 3 days ago. China Pharma Holdings, Inc. Common Stock (AMEX:CPHI) shares rose 42.9% to $0.47. As per the news, the Q1 earnings report came out 3 days ago. Kintara Therapeutics (NASDAQ:KTRA) shares rose 28.95% to $0.18. The market value of their outstanding shares is at $7.1 million. The company's, Q3 earnings came out 4 days ago. PTC Therapeutics (NASDAQ:PTCT) stock rose 26.9% to $42.0. The market value of their outstanding shares is at $3.2 billion. China SXT Pharmaceuticals (NASDAQ:SXTC) stock i

Shares of Alibaba Group Holding Limited (NYSE:BABA) fell sharply during Tuesday's session following mixed first-quarter financial results. The e-commerce giant reported fiscal fourth-quarter 2023 revenue growth of 7% year-on-year to $30.73 billion, beating the analyst consensus estimate of $30.40 billion. Adjusted earnings per ADS of $1.40 missed the analyst consensus estimate of $1.41, according to data from Benzinga Pro. Alibaba Group shares tumbled 6.8% to $78.86 on Tuesday. Here are some other stocks moving in today’s mid-day session. Gainers Cheetah Net Supply Chain Service Inc. (NASDAQ:CTNT) shares jumped 352.4% to $5.34 as the company reported pricing of $8.19 million